Croda announced all its excipient manufacturing sites globally are now EXCiPACT certified. This certifies all its leading excipient sites manufacture pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.
Manufacturing processes, quality systems, quality management and the storage and distribution of pharmaceutical excipients have been inspected throughout the audits. The global certifications assure optimal product quality and security within the supply chain in order to guarantee product safety.
"This achievement brings significant value to both Croda and our customers, reducing the audit burden on both sides whilst maintaining confidence in Croda's compliance to the demanding standards of the Pharmaceutical industry,” Dave Cherry, Managing Director of Croda’s Health Care business said. “The certificate assures our customers that Croda manufactures and distributes pharmaceutical excipients to EXCiPACT good manufacturing (GMP) standards. It is a measure of excellence in quality and an assurance for our customers that they are always in receipt of material of the highest standards."